Skip to main content
Top
Published in: Clinical Rheumatology 1/2005

01-02-2005 | Original Article

Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms

Authors: Elisabetta Danieli, Paolo Airò, Lorenzo Bettoni, Massimo Cinquini, Chiara M. Antonioli, Ilaria Cavazzana, Franco Franceschini, Roberto Cattaneo

Published in: Clinical Rheumatology | Issue 1/2005

Login to get access

Abstract

The aim of this study was to evaluate health-related quality of life (HR-QOL) in patients with systemic sclerosis (SSc), to compare it with that of patients with rheumatoid arthritis (RA), and to correlate it with other parameters. HR-QOL was evaluated by the Short Form 36 (SF-36), SSc disease activity and severity by preliminary indexes recently proposed, disability by the Health Assessment Questionnaire (HAQ), and depressive symptoms by the Beck Depression Inventory. HR-QOL perception was not statistically different in patients with SSc and RA, except that patients with diffuse cutaneous involvement had worse scores in the general health and mental health dimensions than patients with RA (p=0.03). Compared with RA, patients with SSc tended to perceive less bodily pain (p=0.06) and have less disability (p=0.04) but to report higher depressive symptom scores (p=0.05). SSc patients’ HR-QOL was associated with some disease severity scales (general, kidney and, less significantly, heart), but it was poorly correlated with the other evaluated disease activity and severity indexes. A strong correlation with disability and with depressive symptoms was observed. In conclusion, patients with SSc perceived a reduced HR-QOL similar to that of patients with RA. SF-36 may provide useful information in their evaluation.
Literature
1.
go back to reference Haythornthwaite JA, Heinberg LJ, McGuire L (2003) Psychological factors in scleroderma. Rheum Dis Clin North Am 29:427–439PubMedCrossRef Haythornthwaite JA, Heinberg LJ, McGuire L (2003) Psychological factors in scleroderma. Rheum Dis Clin North Am 29:427–439PubMedCrossRef
2.
go back to reference Calkins DR, Rubenstein LV, Cleary PD, et al. (1991) Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med 114:451–454PubMedCrossRef Calkins DR, Rubenstein LV, Cleary PD, et al. (1991) Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med 114:451–454PubMedCrossRef
3.
go back to reference Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef
4.
go back to reference Brazier JE, Harper R, Jones MB, et al. (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160–164PubMedCentralPubMedCrossRef Brazier JE, Harper R, Jones MB, et al. (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160–164PubMedCentralPubMedCrossRef
5.
go back to reference Mc Horney CA, Ware JE, Lu JFR (1994) The MOS 36-item short-form health survey (SF-36). III. Tests of data quality, scaling assumptions and reliability across diverse patient groups. Med Care 32:40–66CrossRef Mc Horney CA, Ware JE, Lu JFR (1994) The MOS 36-item short-form health survey (SF-36). III. Tests of data quality, scaling assumptions and reliability across diverse patient groups. Med Care 32:40–66CrossRef
6.
go back to reference Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russel IT (1993) The SF-36 Health Survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 306:1440–1444PubMedCentralPubMedCrossRef Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russel IT (1993) The SF-36 Health Survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 306:1440–1444PubMedCentralPubMedCrossRef
7.
go back to reference Talamo J, Frater A, Gallivan S, Young A (1997) Use of the short-form (SF-36) for health status measurement in rheumatoid arthritis. Br J Rheumatol 36:463–469PubMedCrossRef Talamo J, Frater A, Gallivan S, Young A (1997) Use of the short-form (SF-36) for health status measurement in rheumatoid arthritis. Br J Rheumatol 36:463–469PubMedCrossRef
8.
go back to reference Husted JA, Gladman DD, Farewell VT, Long JA, Cook RJ (1997) Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 24:511–517PubMed Husted JA, Gladman DD, Farewell VT, Long JA, Cook RJ (1997) Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 24:511–517PubMed
9.
go back to reference DaCosta D, Dobkin PL, Fitzcharles MA, et al. (2000) Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol 27:365–372 DaCosta D, Dobkin PL, Fitzcharles MA, et al. (2000) Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol 27:365–372
10.
go back to reference Ruta DA, Hursat MP, Kind P, Hunter M, Shibbings A (1998) Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the Short-Form 36-item health survey (SF-36). Br J Rheumatol 37:425–436PubMedCrossRef Ruta DA, Hursat MP, Kind P, Hunter M, Shibbings A (1998) Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the Short-Form 36-item health survey (SF-36). Br J Rheumatol 37:425–436PubMedCrossRef
11.
go back to reference Kvien TK, Kaasa S, Smedstad LM (1998) Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 51:1077–1086PubMedCrossRef Kvien TK, Kaasa S, Smedstad LM (1998) Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 51:1077–1086PubMedCrossRef
12.
go back to reference Hill CL, Parsons J, Taylor A, Leach G (1999) Health related quality of life in a population sample with arthritis. J Rheumatol 26:2029–2035PubMed Hill CL, Parsons J, Taylor A, Leach G (1999) Health related quality of life in a population sample with arthritis. J Rheumatol 26:2029–2035PubMed
13.
go back to reference Strombeck B, Ekdahl C, Manthorpe R, Wilkstrom I, Jacibsson L (2000) Health-related quality of life in primary Sjögren’s syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 29:20–28PubMedCrossRef Strombeck B, Ekdahl C, Manthorpe R, Wilkstrom I, Jacibsson L (2000) Health-related quality of life in primary Sjögren’s syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 29:20–28PubMedCrossRef
14.
go back to reference Husted JA, Gladman DD, Farewell VT, Cook RJ (2001) Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 45:151–158PubMedCrossRef Husted JA, Gladman DD, Farewell VT, Cook RJ (2001) Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 45:151–158PubMedCrossRef
15.
go back to reference Wiles NJ, Scott DGI, Barrett EM, et al. (2001) Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire: and the short-form (SF-36) in a community and a clinic based sample. Ann Rheum Dis 60:956–961PubMedCentralPubMedCrossRef Wiles NJ, Scott DGI, Barrett EM, et al. (2001) Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire: and the short-form (SF-36) in a community and a clinic based sample. Ann Rheum Dis 60:956–961PubMedCentralPubMedCrossRef
16.
go back to reference Suarez-Alzamor ME, Ahn C, Friedman AW, et al. (2000) Performance of outcome measures in systemic sclerosis (abstract). Arthritis Rheum 43:S319 Suarez-Alzamor ME, Ahn C, Friedman AW, et al. (2000) Performance of outcome measures in systemic sclerosis (abstract). Arthritis Rheum 43:S319
17.
go back to reference Grove ML, Wilson A, Raza K, Carruthers DM, Bacon P (2000) Patients with damage from primary systemic vasculitides experience impaired physical health as measured by the SF-36 (abstract). Arthritis Rheum 43:S368 Grove ML, Wilson A, Raza K, Carruthers DM, Bacon P (2000) Patients with damage from primary systemic vasculitides experience impaired physical health as measured by the SF-36 (abstract). Arthritis Rheum 43:S368
18.
go back to reference Cossutta R, Zeni S, Soldi A, Colombelli P, Belotti Masserini A, Fantini F (2002) Evaluation of quality of life in patients with systemic sclerosis by the SF-36 questionnaire (in Italian). Reumatismo 54:122–127PubMed Cossutta R, Zeni S, Soldi A, Colombelli P, Belotti Masserini A, Fantini F (2002) Evaluation of quality of life in patients with systemic sclerosis by the SF-36 questionnaire (in Italian). Reumatismo 54:122–127PubMed
19.
go back to reference Subcommittee for Scleroderma Criteria of the American Rheumatism Association diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 23:581–590CrossRef Subcommittee for Scleroderma Criteria of the American Rheumatism Association diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 23:581–590CrossRef
20.
go back to reference Arnett FC, Edworthy SM, Block DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Block DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
21.
go back to reference LeRoy EC, Black C, Fleischmayer R, et al. (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–208PubMed LeRoy EC, Black C, Fleischmayer R, et al. (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–208PubMed
22.
go back to reference Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51:1025–1036PubMedCrossRef Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51:1025–1036PubMedCrossRef
23.
go back to reference Steen VD, Mesdger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scale to demonstrate change in systemic sclerosis over time. Arthritis Rheum 40:1984–1991PubMedCrossRef Steen VD, Mesdger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scale to demonstrate change in systemic sclerosis over time. Arthritis Rheum 40:1984–1991PubMedCrossRef
24.
go back to reference Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:53–63CrossRef Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:53–63CrossRef
25.
go back to reference Mesdger TA Jr, Silman AJ, Steen VD, et al. (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167 Mesdger TA Jr, Silman AJ, Steen VD, et al. (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167
26.
go back to reference Valentini G, Della Rossa A, Bombardieri S, et al. (2001) European multicentre study to define activity criteria for systemic sclerosis. II Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60:592–598PubMedCentralPubMedCrossRef Valentini G, Della Rossa A, Bombardieri S, et al. (2001) European multicentre study to define activity criteria for systemic sclerosis. II Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60:592–598PubMedCentralPubMedCrossRef
27.
go back to reference van der Heijde DM, van’t Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van LeeuwenMA, et al. (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49:916–920CrossRef van der Heijde DM, van’t Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van LeeuwenMA, et al. (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49:916–920CrossRef
28.
go back to reference Bettoni L, Geri P, Airò P, et al. (2002) Systemic sclerosis therapy with Iloprost. A prospective observational study of 30 patients treated for a median of 3 years. Clin Rheumatol 21:244–250PubMedCrossRef Bettoni L, Geri P, Airò P, et al. (2002) Systemic sclerosis therapy with Iloprost. A prospective observational study of 30 patients treated for a median of 3 years. Clin Rheumatol 21:244–250PubMedCrossRef
29.
go back to reference Merkel PA, Herlyn K, Martin RW, et al. (2002) Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon. Arthritis Rheum 46:2410–2420PubMedCrossRef Merkel PA, Herlyn K, Martin RW, et al. (2002) Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon. Arthritis Rheum 46:2410–2420PubMedCrossRef
30.
go back to reference Clements PJ, Wong WK, Hurwitz EL, et al. (1999) Correlates of the Disability Index of the Health Assessment Questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum 42:2372–2380PubMedCrossRef Clements PJ, Wong WK, Hurwitz EL, et al. (1999) Correlates of the Disability Index of the Health Assessment Questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum 42:2372–2380PubMedCrossRef
31.
go back to reference Clements PJ, Wong WK, Hurwitz EL, et al. (2001) The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 44:653–661PubMedCrossRef Clements PJ, Wong WK, Hurwitz EL, et al. (2001) The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 44:653–661PubMedCrossRef
32.
go back to reference Roca RP, Wigley FM, White B (1996) Depressive symptoms associated with scleroderma. Arthritis Rheum 39:1035–1040PubMedCrossRef Roca RP, Wigley FM, White B (1996) Depressive symptoms associated with scleroderma. Arthritis Rheum 39:1035–1040PubMedCrossRef
33.
go back to reference Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, et al. (2002) The impact of pain and symptoms of depression in scleroderma. Pain 95:267–275PubMedCrossRef Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, et al. (2002) The impact of pain and symptoms of depression in scleroderma. Pain 95:267–275PubMedCrossRef
34.
go back to reference Newman S, Mulligan K (2000) The psychology of rheumatic diseases. Baillieres Clin Rheumatol 14:773–786CrossRef Newman S, Mulligan K (2000) The psychology of rheumatic diseases. Baillieres Clin Rheumatol 14:773–786CrossRef
35.
go back to reference Moser DK, Clements PJ, Brecht ML, Weiner SR (1993) Predictors of psychosocial adjustment in systemic sclerosis. The influence of formal education level, functional ability, hardness, uncertainty, and social support. Arthritis Rheum 36:1398–1405PubMedCrossRef Moser DK, Clements PJ, Brecht ML, Weiner SR (1993) Predictors of psychosocial adjustment in systemic sclerosis. The influence of formal education level, functional ability, hardness, uncertainty, and social support. Arthritis Rheum 36:1398–1405PubMedCrossRef
36.
go back to reference Benrud-Larson LM, Heinberg LJ, Haythornthwaite JA, et al. (2002) Body image dissatisfaction in scleroderma: extent and relationship to psychosocial function. Health Psychol 22:130–139CrossRef Benrud-Larson LM, Heinberg LJ, Haythornthwaite JA, et al. (2002) Body image dissatisfaction in scleroderma: extent and relationship to psychosocial function. Health Psychol 22:130–139CrossRef
Metadata
Title
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms
Authors
Elisabetta Danieli
Paolo Airò
Lorenzo Bettoni
Massimo Cinquini
Chiara M. Antonioli
Ilaria Cavazzana
Franco Franceschini
Roberto Cattaneo
Publication date
01-02-2005
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2005
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-0970-z

Other articles of this Issue 1/2005

Clinical Rheumatology 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.